Drugs / Wide-spectrum nutritional supplement
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03835117 | Feb 2020 → Jul 2022 | autism spectrum disorder | Rossignol Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wide-spectrum nutritional supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03835117 ↗ |
| Route | Oral | “The daily serving size will be divided into two oral daily doses” NCT03835117 ↗ |